Here’s the latest from the FDA on blood pressure meds with a cancer-causing element

With blood pressure patients on edge after numerous recalls of valsartan, losartan and irbesartan for too much NDEA, FDA commissioner Scott Gottlieb and Center for Drug Evaluation and Research Director … Click to Continue »